Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Low Rates of Vancomycin Use in Febrile Neutropenia: A Multicenter Study

André Domingues Pereira, MD, Jessica Fernandes Ramos, MD PhD, Mariana Guarana, MD, Simone A Nouér, MD PhD, Marcio Nucci, MD PhD, Celso Arrais-Rodrigues, MD PhD

Blood (2019) 134 (Supplement_1): 4755.

https://doi.org/10.1182/blood-2019-132271

Published: 2019

Journal Articles

Greatalys: Generating Real World Evidence across Italy in Sickle Cell Disease

Chiara Castiglioni, Claudia Condorelli, Paola Amore, Valentina Perrone, Davide Alessandrini, Chiara Veronesi, Luca Degli Esposti, Eleonora Premoli, Carina Fiocchi

Blood (2019) 134 (Supplement_1): 4707.

https://doi.org/10.1182/blood-2019-125612

Published: 2019

Journal Articles

Significant Differences in Test Availability and Access to Novel Drugs for Multiple Myeloma between Public and Private Hospitals in Latin America. Grupo De Estudio Latinoamericano De Mieloma Multiple (GELAMM)

Eloisa Riva, MD, Natalia Paola Schutz, MD, Camila Peña, MD, Fiorella Villano, MD, Guillermo J. Ruiz-Argüelles, FRCP, MACP, Juan Ramon Navarro, MD, Willem Bujan, MD, Lidiane Andino Neves, MD, Christine Rojas, MD, Hernán López-Vidal, MD, Angelina Rodriguez, MD, Virginia Bove, MD, Miguel Rodriguez, MD, Dorotea Beatriz Fantl, MD

Blood (2018) 132 (Supplement 1): 2244.

https://doi.org/10.1182/blood-2018-99-111429

Published: 2018

Journal Articles

Costs and in-Hospital Mortality Rates in Autologous Stem Cell Transplant for Multiple Myeloma: An Analysis of the Nationwide Inpatient Sample (NIS) Database

Yuzhou Liu, MD, Hedong Han, MD, Xin Wei, MD, Qian Wang, MD MPH, Jia He, MD PhD, Gunjan L. Shah, MD, Sergio A. Giralt, MD, Ola Landgren, MD PhD, Alexander Lesokhin, MD

Blood (2017) 130 (Supplement 1): 2108.

https://doi.org/10.1182/blood.V130.Suppl_1.2108.2108

Published: 2017

Journal Articles

Correlation of c-MPL Expression and Platelet Count in Thrombocytopenia Due to Chemotherapy Patients

Irza Wahid, MD PhD, Tubagus Djumhana Atmakusuma, MDPhD

Blood (2017) 130 (Supplement 1): 4863.

https://doi.org/10.1182/blood.V130.Suppl_1.4863.4863

Published: 2017

Journal Articles

Impact of Immunohistochemistry-Defined Cell of Origin and MYC Rearrangements on Outcomes in Patients with PET-Defined Stage I/II Diffuse Large B-Cell Lymphoma Treated with R-CHOP ± Radiotherapy: An International Multi-Center Retrospective Study

Allison Barraclough, MBBS, Musa Alzahrani, Marianne Schmidt Ettrup, Mark Bishton, Chris Van Vliet, Laurie H. Sehn, MDMPH, Vishakha Sovani, Mitchell Steven Ward, Bradley Augustson, Pedro Farinha, Jorne Lionel Biccler, MSc, Joseph M Connors, MD, David W. Scott, MD PhD FRACP, FRCPA, Kerry J Savage, MD, Tarec Christoffer El-Galaly, MD PhD, Diego Villa, MD, Chan Yoon Cheah

Blood (2017) 130 (Supplement 1): 415.

https://doi.org/10.1182/blood.V130.Suppl_1.415.415

Published: 2017

Journal Articles

BGB-3111 in Combination with Obinutuzumab in Patients with Chronic Lymphocytic Leukemia and Follicular Lymphoma

Constantine S. Tam, MD, Hang Quach, MBBS, MD, Andrew Nicol, Xavier Badoux, Hannah Rose, H. Miles Prince, MD FRACP, FRCPA, Michael F. Leahy, FRACP,FRCPath,FRCP, Richard Eek, MBCHB, Nicholas Wickham, FRCPA,FRACP,FRCPath, Sushrut S. Patil, FRACP, FRCPA, Jane Huang, MD, Xiaoping Zhang, MD PhD, Lai Wang, PhD, Eric Hedrick, MD, William Novotny, Ian W. Flinn, MD PhD

Blood (2017) 130 (Supplement 1): 1745.

https://doi.org/10.1182/blood.V130.Suppl_1.1745.1745

Published: 2017

Journal Articles

Efficacy and Safety of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in the Phase 2 ACE-LY-004 Study

Blood (2017) 130 (Supplement 1): 155.

https://doi.org/10.1182/blood.V130.Suppl_1.155.155

Published: 2017

Journal Articles

Emergency Department Utilization By Hemophilia Patients in United States

Abdulhafiz Zakieh, MD, Maha Al-Ghafry, MD, Divya Nadella, BS, Hamayun Imran, MD, Abdul H Siddiqui, MBBS, MD

Blood (2016) 128 (22): 3799.

https://doi.org/10.1182/blood.V128.22.3799.3799

Published: 2016

Journal Articles

Survival into Adulthood in Sickle Cell Disease from the Dallas Newborn Cohort

Melissa D. Mathias, MD, Song Zhang, PhD, Zora R. Rogers, MD, George R. Buchanan, MD, Alecia C. Nero, MD, Timothy L. McCavit, MD MS

Blood (2014) 124 (21): 559.

https://doi.org/10.1182/blood.V124.21.559.559

Published: 2014

Journal Articles

Should Albumin Be Considered a Prognostic Factor For Brazilian Patients Diagnosed With Classical Hodgkin Lymphoma

Guilherme Fleury Perini, MD, Egyla M Cavalcante, MD, Joao Garibaldi Rezende, Jr, MD, Davimar Miranda Borducchi, MD, Fernanda Cunha Vieira, Danielle Leao Cordeiro Faria, MD, Renato S Tavares, Fabio Pires de Souza Santos, MD, Nelson Hammershlack, MD, PhD, Karin Zattar Cecyn, Eni Maria Souza, M.D, PhD, Adriana M. Damasco Penna, M.D, Otavio C.G. Baiocchi, MD, PhD

Blood (2013) 122 (21): 5049.

https://doi.org/10.1182/blood.V122.21.5049.5049

Published: 2013

Journal Articles

Differences In Treatment and Diagnostic Patterns In Private Vs Public Sectors For Deletion 5Q Myelodysplastic Syndromes (MDS) In Mexico: Results From A Physician Survey

Michelle Ann Soriano, PhD, Roberto Ovilla, MD, Maria Guadalupe Rodríguez-González, MD, Renée Arnold, PharmD, RPh, Dalia Mahmoud, MBA

Blood (2013) 122 (21): 5593.

https://doi.org/10.1182/blood.V122.21.5593.5593

Published: 2013

Journal Articles

Predictors Of Vena Cava Filter Use For Venous Thromboembolism In Cancer Patients

Gwendolyn Ho, MD, Ann Brunson, BS, Richard H. White, MD, Ted Wun, MD, FACP

Blood (2013) 122 (21): 935.

https://doi.org/10.1182/blood.V122.21.935.935

Published: 2013

Journal Articles

The Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies: Physicians and Patients Points of View and Interactions.

Yvan Beaussant, Lionel Pazart, Christophe Tournigand, Florence Mathieu-Nicot, Elodie Cretin, Eric Deconinck, MD, PhD, Régis Aubry, PhD

Blood (2011) 118 (21): 2076.

https://doi.org/10.1182/blood.V118.21.2076.2076

Published: 2011

Journal Articles

A Worldwide Observational Registry Collecting Longitudinal Data on Management of Chronic Myeloid Leukemia Patients (The WORLD CML Registry) – 2nd Annual Interim Analysis

Ricardo Pasquini, MD, Jorge Cortes, MD, Hagop M. Kantarjian, MD, David Joske, MBBS, FRCPA, FRACP, Luis A Meillon, MD, Lidia Mongay, MD, PhD, MBA, John Reynolds, PhD, Timothy Hughes, MD, MBBS, Dong-Wook Kim, MD

Blood (2010) 116 (21): 2292.

https://doi.org/10.1182/blood.V116.21.2292.2292

Published: 2010

Journal Articles

A Worldwide Observational Registry Collecting Longitudinal Data On the Management of CML Patients (The WORLD CML Registry) - Summary of the First 1001 Patients.

Ricardo Pasquini, MD, Jorge Cortes-Franco, MD, Hagop M. Kantarjian, MD, David Joske, MBBS, FRCPA, FRACP, Zhixiang Shen, MD, PhD, Luis Meillon, MD, Lidia Mongay, MD, PhD, MBA, Dawn F. Eng, Jim Wang, PhD, Timothy P. Hughes, MD, MBBS, Dong-Wook Kim, MD, PhD

Blood (2009) 114 (22): 4267.

https://doi.org/10.1182/blood.V114.22.4267.4267

Published: 2009

Journal Articles

What Happens to Children with Leukemia and Lymphoma after Diagnosis in Developing World?.

Satya Prakash Yadav, DNB, Sunil Dutt Sharma, DCH, Ruchira Misra, DNB, Anupam Sachdeva, MD

Blood (2006) 108 (11): 5519.

https://doi.org/10.1182/blood.V108.11.5519.5519

Published: 2006

Journal Articles

Inpatient Pharmaceutical Cost of Hematological Agents: A Single Center Report.

Charles V. Wendling, MD, Jonathan Glass, MD, Perry G. Rigby, MD

Blood (2006) 108 (11): 5491.

https://doi.org/10.1182/blood.V108.11.5491.5491

Published: 2006

Journal Articles

Darbepoetin Alfa (DA) - Pattern of Use and Outcomes in Adult Patients with Non-Myeloid Malignancies and Chemotherapy-Induced Anemia: A French Observational Study.

Arnaud P.M. Pigneux, MD, Isabelle L. Ray-Coquard, MD, Philippe J.M. Dalivoust, MD, Gaelle Chenuc Biostat, Anne M. Bastie, MD

Blood (2006) 108 (11): 3347.

https://doi.org/10.1182/blood.V108.11.3347.3347

Published: 2006

Journal Articles

Provision of Peripheral Blood Stem Cell Service in Developing World: Experience from a Private Medical Center in Malaysia.

Ng Soo Chin, FRCP, FRCPA, Alan Teh, FRCP, K.M. Tan

Blood (2005) 106 (11): 5547.

https://doi.org/10.1182/blood.V106.11.5547.5547

Published: 2005

NARROW

Low Rates of Vancomycin Use in Febrile Neutropenia: A Multicenter Study

Greatalys: Generating Real World Evidence across Italy in Sickle Cell Disease

Significant Differences in Test Availability and Access to Novel Drugs for Multiple Myeloma between Public and Private Hospitals in Latin America. Grupo De Estudio Latinoamericano De Mieloma Multiple (GELAMM)

Costs and in-Hospital Mortality Rates in Autologous Stem Cell Transplant for Multiple Myeloma: An Analysis of the Nationwide Inpatient Sample (NIS) Database

Correlation of c-MPL Expression and Platelet Count in Thrombocytopenia Due to Chemotherapy Patients

Impact of Immunohistochemistry-Defined Cell of Origin and MYC Rearrangements on Outcomes in Patients with PET-Defined Stage I/II Diffuse Large B-Cell Lymphoma Treated with R-CHOP ± Radiotherapy: An International Multi-Center Retrospective Study

BGB-3111 in Combination with Obinutuzumab in Patients with Chronic Lymphocytic Leukemia and Follicular Lymphoma

Efficacy and Safety of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in the Phase 2 ACE-LY-004 Study

Emergency Department Utilization By Hemophilia Patients in United States

Survival into Adulthood in Sickle Cell Disease from the Dallas Newborn Cohort

Should Albumin Be Considered a Prognostic Factor For Brazilian Patients Diagnosed With Classical Hodgkin Lymphoma

Differences In Treatment and Diagnostic Patterns In Private Vs Public Sectors For Deletion 5Q Myelodysplastic Syndromes (MDS) In Mexico: Results From A Physician Survey

Predictors Of Vena Cava Filter Use For Venous Thromboembolism In Cancer Patients

The Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies: Physicians and Patients Points of View and Interactions.

A Worldwide Observational Registry Collecting Longitudinal Data on Management of Chronic Myeloid Leukemia Patients (The WORLD CML Registry) – 2nd Annual Interim Analysis

A Worldwide Observational Registry Collecting Longitudinal Data On the Management of CML Patients (The WORLD CML Registry) - Summary of the First 1001 Patients.

What Happens to Children with Leukemia and Lymphoma after Diagnosis in Developing World?.

Inpatient Pharmaceutical Cost of Hematological Agents: A Single Center Report.

Darbepoetin Alfa (DA) - Pattern of Use and Outcomes in Adult Patients with Non-Myeloid Malignancies and Chemotherapy-Induced Anemia: A French Observational Study.

Provision of Peripheral Blood Stem Cell Service in Developing World: Experience from a Private Medical Center in Malaysia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only